3624 results for «2509»
3624 results
New, novel Navitor TAVI valve with active paravalvular leak-sealing technology
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard to learn about the latest TAVI active PVL-sealing technology, to understand the clinical evidence with the active PVL-sealing technology, and to discuss the value that the new, novel Navitor valve brings in today's TAVI market.
View the recording of this EuroPCR 2021 Session...
Guiding primary PCI using high-definition intravascular ultrasound
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.
Clinical event reductions in high-risk hypertension patients treated with renal denervation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...
BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes
18 May 2021 – From EuroPCR 2021
Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.
Modern PCI: how OCT, with the new ULTREON 1.0 software, supports you in guiding and optimising your procedure: a calcified lesion
20 May 2021 – From EuroPCR 2021
Watch this session presented by Zsolt Piroth, Emanuele Barbato, William Wijns, Carlos Collet, Tommaso Gori, Niels Van Royen and Antonio Maria Leone in order to receive tips and tricks demonstrating how physiology and/or intra-vascular imaging can be integrated in your everyday PCI, and to learn more about...
How CT fusion can empower your structural heart procedures
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Modine, Erwan Donal, Julia Grapsa and Ronak Rajani in order to learn how the novel tools in 4D TEE can help improving visualisation, navigation and communication within the heart team and how to better plan your structural heart procedures with Echo...
Coronary physiology in STEMI: is OpSens OptoWire III a game-changer in complete revascularisation?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Engstrom, Zsolt Piroth, Jacques Monsegu and Giuseppe Biondi-Zoccai in order to get an update on the latest evidence in physiology-guided full revascularisation in STEMI patients, to discover how the innovative physiology wire, OptoWire III from OpSens may lower the barriers to approach...
Contemporary adoption of invasive coronary physiology with microcatheter-based technology
19 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Bernard De Bruyne, Jeroen Sonck, Simone Biscaglia, Salvatore Brugaletta and Carlos Collet in order to understand the role of microcatheter-based physiology also through a critical appraisal of the available literature, to know how to correctly adopt the novel TruePhysio microcatheter, and...
PCI of calcified coronaries - we will rock you! (Part 2) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for Orbital atherectomy.
This session was originally presented during EuroPCR 2021.
Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
19 May 2021 – From EuroPCR 2021
Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic...
A case-based approach: finding balance between bleeding and ischemic risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...
PCI of calcified coronaries - we will rock you! - Part 3
18 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for IntraVascular Lithotripsy.
This session was originally presented during EuroPCR 2021.
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
EuroPCR 2021: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine
18 May 2021 – From EuroPCR 2021
Did you miss the livestream of EuroPCR 2021’s official Opening Ceremony? Look back to watch the PCR Chairman William Wijns and PCR Vice-Chairman Jean Fajadet launch this innovative edition of the Course. More than ever it was the right place to be!
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
Multivessel disease revascularisation: balancing the risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...
Shock the Rock: new intravascular lithotripsy real-world data and cases
18 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Holger Nef, Arif Al Nooryani, Alfonso Ielasi, Michael Haude, Margaret McEntegart and Flavio Luciano Ribichini in order to learn how to optimally adopt Intravascular Lithotripsy (IVL) for treatment of calcified lesions, to identify best practices when using IVL in different clinical settings,...
Challenges and opportunities in high-risk patients undergoing TAVI
19 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in bifurcation lesions:
- EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
- Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
EBC Main: Behind the curtain
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith in order to have additional information about the EBC main trial, to learn about the principal investigator's interpretation of results, and to find out about the European Bifurcation Club's remaining questions to be addressed in future trials.
